US-20260124384-A1 - TELEMEDICINE AND INTELLIGENT INJECTION DEVICE SYSTEMS AND METHODS INTEGRATION

US20260124384A1US 20260124384 A1US20260124384 A1US 20260124384A1US-20260124384-A1

Abstract

A device may establish communication between the intelligent injection device and a telemedicine platform configured to facilitate healthcare personnel interaction with patients. A device may receive, via the telemedicine platform, healthcare personnel instructions for medication administration to a patient. A device may unlock the intelligent injection device to permit medication administration. A device may automatically transmit, via a wireless module, medication administration data from the intelligent injection device to the telemedicine platform in response to a confirmed dose administration using the intelligent injection device. A device may record the medication administration data in an electronic patient portal comprising a medical chart accessible by both healthcare personnel and the patient.

Inventors

Jeremy Corbett

Assignees

DATADOSE, LLC

Dates

Publication Date: 20260507
Application Date: 20251029

Claims (20)

1 . A method for telemedicine-enabled medication administration comprising: providing an intelligent injection device comprising a barrel in fluid communication with a needle, a piston positioned within the barrel, and a microprocessor in electronic communication with a wireless module and a switch; establishing communication between the intelligent injection device and a telemedicine platform configured to facilitate healthcare personnel interaction with patients; receiving, via the telemedicine platform, healthcare personnel instructions for medication administration to a patient; unlocking the intelligent injection device to permit medication administration; automatically transmitting, via the wireless module, medication administration data from the intelligent injection device to the telemedicine platform in response to a confirmed dose administration using the intelligent injection device; recording the medication administration data in an electronic patient portal comprising a medical chart accessible by both healthcare personnel and the patient; and storing the medication administration data on the telemedicine platform for healthcare personnel review.
2 . The method of claim 1 , wherein the unlocking step includes verifying that a temperature sensed by the temperature sensor is within a predetermined safe range for the medication before unlocking the intelligent injection device.
3 . The method of claim 1 , wherein the intelligent injection device further comprises a damage detection system in electronic communication with the microprocessor for detecting damage to the device, and wherein the method further comprises preventing unlocking of the intelligent injection device when damage is detected.
4 . The method of claim 1 , wherein the intelligent injection device further comprises a timestamping system in electronic communication with the microprocessor, and wherein the medication administration data includes timestamp data indicating exact timing of injection events.
5 . The method of claim 1 , wherein unlocking the intelligent injection device comprises performing patient verification using at least one of username verification, password verification, patient ID verification, face verification, retinal verification, vocal verification, fingerprint verification, or digital certificate verification.
6 . The method of claim 1 , further comprising integrating with one or more wearable devices for patient notification delivery.
7 . The method of claim 1 , wherein the telemedicine platform includes a virtual care assistant configured to provide patient guidance through at least one of voice-activated medication management interfaces, hands-free interaction capabilities, or mobile device applications with interactive medication management interfaces.
8 . The method of claim 1 , further comprising collecting geolocation data from the intelligent injection device and analyzing the geolocation data alongside the medication administration data to provide location-specific healthcare delivery information.
9 . The method of claim 1 , further comprising receiving data collected by one or more Internet of Things (IoT) devices.
10 . The method of claim 1 , wherein the telemedicine platform includes artificial intelligence capabilities configured to analyze administration data and provide feedback to healthcare personnel through an automated alert.
11 . The method of claim 10 , wherein the automated alert is triggered by at least one of a missed dose, a medication error, an adverse event, or a system malfunction.
12 . A mesh-networked telemedicine system for coordinated medication administration comprising: a plurality of intelligent injection devices, each comprising a microprocessor in electronic communication with a wireless module configured for mesh network communication; a telemedicine platform configured with mesh network infrastructure to enable communication between the plurality of intelligent injection devices, monitoring systems, and healthcare provider devices to create an integrated medication coordination ecosystem; device-to-device communication protocols that allow the intelligent injection devices to communicate directly with other networked devices for real-time coordination of medication administration events; drug interaction analysis capabilities configured to identify potential adverse interactions based on medication types administered through connected intelligent injection devices, dosing schedules, and administration timing data; medication administration timing coordination across the plurality of intelligent injection devices within the mesh network to prevent conflicting medication schedules; an electronic patient portal comprising an interface configured to: receive and store administration data from the plurality of intelligent injection devices in the mesh network, present coordinated medication administration information to healthcare personnel, enable healthcare personnel and patient access to medication administration records across networked devices, provide data synchronization capabilities to maintain consistent medication administration data across networked devices; and wherein the telemedicine platform is configured to optimize dosing intervals based on drug interaction analysis results and synchronize administration events across the mesh network to maintain consistent medication levels and maximize therapeutic benefits.
13 . The mesh-networked telemedicine system of claim 12 , wherein each intelligent injection device further comprises a temperature sensor in electronic communication with the microprocessor, and wherein the telemedicine platform is configured to prevent medication administration when the temperature sensor detects that a medication temperature is outside a predetermined safe range.
14 . The mesh-networked telemedicine system of claim 12 , wherein each intelligent injection device further comprises a damage detection system in electronic communication with the microprocessor for detecting device damage, and wherein the telemedicine platform is configured to prevent device unlocking when damage is detected across the mesh network.
15 . The mesh-networked telemedicine system of claim 12 , wherein each intelligent injection device further comprises a timestamping system in electronic communication with the microprocessor, and wherein the medication administration data transmitted through the mesh network includes timestamp data indicating exact timing of injection events for coordination across networked devices.
16 . The mesh-networked telemedicine system of claim 12 , wherein the telemedicine platform is configured to perform patient verification through the mesh network using one at least one of username verification, password verification, patient ID verification, face verification, retinal verification, vocal verification, fingerprint verification, or digital certificate verification before unlocking intelligent injection devices.
17 . The mesh-networked telemedicine system of claim 12 , further comprising integration with a wearable device through the mesh network for patient monitoring and notification delivery, wherein the wearable device provides real-time physiological data that influences medication coordination decisions with the intelligent injection device.
18 . The mesh-networked telemedicine system of claim 12 , further comprising geolocation detection systems that collect real-time coordinates from the plurality of intelligent injection devices, wherein the telemedicine platform analyzes geolocation data alongside medication administration data to provide location-specific healthcare delivery insights and optimize resource allocation across the mesh network.
19 . The mesh-networked telemedicine system of claim 12 , wherein the telemedicine platform includes artificial intelligence capabilities configured to analyze administration data from the mesh network and provide immediate feedback to healthcare personnel through an automated alert.
20 . The mesh-networked telemedicine system of claim 19 , wherein the automated alert is for at least one of a missed dose, a medication error, an adverse event, or a system malfunction detected across the plurality of intelligent injection devices.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation-in-part of U.S. patent application Ser. No. 19/314,854, filed on Aug. 29, 2025, which is a continuation-in-part of U.S. patent application Ser. No. 19/281,005, filed on Jul. 25, 2025, which is a continuation of U.S. patent application Ser. No. 19/031,862, filed on Jan. 18, 2025, which is a continuation of U.S. patent application Ser. No. 19/030,829, filed on Jan. 17, 2025, which claims the benefit of U.S. provisional application No. 63/715,505, filed on Nov. 1, 2024, which are all hereby incorporated by reference in their entirety. FIELD The present disclosure relates generally to a management platform for injection devices, such as syringes, and, more particularly, to data reporting regarding administration completion of an injectable pharmaceutical. BACKGROUND Understanding administration of drugs and their interaction in the healthcare ecosystem are important in delivering beneficial patient care. Applicant appreciates that regular pharmaceutical therapy and a need for real time data management related to both timing of and compliance in dosing bundled with increased information sharing across the care continuum can provide valuable insight for improving care and, in turn, reducing fraud, waste, and abuse. SUMMARY In some aspects, the techniques described herein relate to a method for telemedicine-enabled medication administration including: providing an intelligent injection device including a barrel in fluid communication with a needle, a piston positioned within the barrel, and a microprocessor in electronic communication with a wireless module and a switch; establishing communication between the intelligent injection device and a telemedicine platform configured to facilitate healthcare personnel interaction with patients; receiving, via the telemedicine platform, healthcare personnel instructions for medication administration to a patient; unlocking the intelligent injection device to permit medication administration; automatically transmitting, via the wireless module, medication administration data from the intelligent injection device to the telemedicine platform in response to a confirmed dose administration using the intelligent injection device; recording the medication administration data in an electronic patient portal including a medical chart accessible by both healthcare personnel and the patient; and storing the medication administration data on the telemedicine platform for healthcare personnel review. In some aspects, the techniques described herein relate to a method, wherein the unlocking step includes verifying that a temperature sensed by the temperature sensor is within a predetermined safe range for the medication before unlocking the intelligent injection device. In some aspects, the techniques described herein relate to a method, wherein the intelligent injection device further includes a damage detection system in electronic communication with the microprocessor for detecting damage to the device, and wherein the method further includes preventing unlocking of the intelligent injection device when damage is detected. In some aspects, the techniques described herein relate to a method, wherein the intelligent injection device further includes a timestamping system in electronic communication with the microprocessor, and wherein the medication administration data includes timestamp data indicating exact timing of injection events. In some aspects, the techniques described herein relate to a method, wherein unlocking the intelligent injection device includes performing patient verification using at least one of username verification, password verification, patient ID verification, face verification, retinal verification, vocal verification, fingerprint verification, or digital certificate verification. In some aspects, the techniques described herein relate to a method, further including integrating with one or more wearable devices for patient notification delivery. In some aspects, the techniques described herein relate to a method, wherein the telemedicine platform includes a virtual care assistant configured to provide patient guidance through at least one of voice-activated medication management interfaces, hands-free interaction capabilities, or mobile device applications with interactive medication management interfaces. In some aspects, the techniques described herein relate to a method, further including collecting geolocation data from the intelligent injection device and analyzing the geolocation data alongside the medication administration data to provide location-specific healthcare delivery information. In some aspects, the techniques described herein relate to a method, further including receiving data collected by one or more Internet of Things (IoT) devices. In some aspects, the techniques described herein relate to a method, wherein the telemedicine platform includes artificial intelligen